Bio-Techne
TECH
237 hedge funds and large institutions have $3.32B invested in Bio-Techne in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 78 increasing their positions, 98 reducing their positions, and 23 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
13% more capital invested
Capital invested by funds: $2.93B → $3.32B (+$389M)
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
1% less funds holding
Funds holding: 240 → 237 (-3)
20% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 98
Top Buyers
Top Sellers
TECH Hedge Fund Activity: Q2 2014 in Review
237 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2014, worth a combined $3.32B — up 13% from $2.93B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of TECH and 21 opened new positions — a net loss of 2 holders — while 98 trimmed existing stakes and 78 added.
The largest buyer was DePrince Race & Zollo Inc (DRZ), opening a new position worth an estimated $42.3M. The largest seller was Macquarie Group, cutting an estimated $53.6M.
- 237 institutional investors held Bio-Techne (TECH) as of Q2 2014, down from 240 in Q1 2014.
- Funds reported $3.32B of Bio-Techne stock for Q2 2014, up 13% quarter-over-quarter.
- 21 funds opened new Bio-Techne positions in Q2 2014 and 23 closed out, a net change of -2 holders.
- The largest Bio-Techne buyer in Q2 2014 was DePrince Race & Zollo Inc (DRZ), an estimated $42.3M added.
- The largest Bio-Techne seller in Q2 2014 was Macquarie Group, an estimated $53.6M sold.
Based on aggregated 13F filings for Q2 2014.